In recent months, UnitedHealth Group has raised premiums by around 20–30%, updated its 2025 earnings guidance, and faced ...

UnitedHealth Group shareholders probably want to forget. However, the health insurance giant should see brighter days ahead.

On Wednesday, a district court finalized the U.S. Department of Justice’s (DOJ) settlement regarding UnitedHealth Group's (NYSE: UNH) acquisition of ...

A political battle continues within the U.S. government over renewing expired Affordable Care Act (ACA) subsidies. The ...

Mairs & Power, an investment advisor, released the third-quarter 2025 investor letter for the “Mairs & Power Balanced Fund.” ...

UnitedHealth Group has agreed to sell its last South American business Banmedica to Brazilian private equity group Patria ...

UnitedHealth Group Inc. defeated an insurance reimbursement suit Tuesday after a federal appeals court affirmed the Employee ...

The health insurance giant's stock got a big boost after Wall Street learned Berkshire Hathaway had invested in it.

Former UnitedHealth Group CEO William McGuire joins mediation team for Fairview and University of Minnesota merger negotiations.

Discover why UnitedHealth Group (UNH) is rated Buy, with margin recovery, earnings growth, and 154% upside potential.

The billionaire saw better places to park his Appaloosa hedge fund's money than in a beleaguered healthcare giant.

UnitedHealth Group Incorporated is a strong long-term buy, with margin growth ahead and rising dividends. Click here to read ...